Nanomind, Inc.

SEC filing

Biotechnology · Stamford, CT

Form D on EDGAR

Amount raised$2Msold at filing

Total offering$3M$1M still open

Investors in the raise8count reported to the SEC

FiledJun 22, 2026first sale May 1, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Aurelia BustosExecutive Officer, Director

Andres TorrubiaExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.